In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Etilen-xantisan tabl Drug Master File in Korea (Etilen-xantisan tabl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Etilen-xantisan tabl. The MFDS reviews the Etilen-xantisan tabl KDMF as part of the drug registration process and uses the information provided in the Etilen-xantisan tabl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Etilen-xantisan tabl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Etilen-xantisan tabl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Etilen-xantisan tabl suppliers with KDMF on PharmaCompass.